Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Improving Drug Delivery for Alzheimer’s Disease Through Nose-to-Brain Delivery Using Nanoemulsions, Nanostructured Lipid Carriers (NLC) and in situ Hydrogels
Sara Cunha, Ben Forbes, José Manuel Sousa Lobo, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 4373-4390
Open Access | Times Cited: 93

Showing 1-25 of 93 citing articles:

On a highway to the brain: A review on nose-to-brain drug delivery using nanoparticles
María Lina Formica, Daniel Andrés Real, Matías L. Picchio, et al.
Applied Materials Today (2022) Vol. 29, pp. 101631-101631
Open Access | Times Cited: 154
Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood–brain barrier (BBB) to manage neurological disorders
Aline de Alcântara Correia, Ana Rita Monteiro, RAYANNA BEATRIZ MARQUES DA SILVA, et al.
Advanced Drug Delivery Reviews (2022) Vol. 189, pp. 114485-114485
Closed Access | Times Cited: 103
Lipid nanoparticle-mediated drug delivery to the brain
Purva Khare, Sara X. Edgecomb, Christine M. Hamadani, et al.
Advanced Drug Delivery Reviews (2023) Vol. 197, pp. 114861-114861
Closed Access | Times Cited: 67
Intranasal drug delivery: The interaction between nanoparticles and the nose-to-brain pathway
Yaoxing Chen, Chenyun Zhang, Yukun Huang, et al.
Advanced Drug Delivery Reviews (2024) Vol. 207, pp. 115196-115196
Closed Access | Times Cited: 36
Lipid-based nanoparticles to address the limitations of GBM therapy by overcoming the blood-brain barrier, targeting glioblastoma stem cells, and counteracting the immunosuppressive tumor microenvironment
Changhong Zhao, Xinshu Zhu, Jianmei Tan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116113-116113
Open Access | Times Cited: 30
Nasal Delivery to the Brain: Harnessing Nanoparticles for Effective Drug Transport
Shivani Gandhi, Divyesh H. Shastri, Jigar Shah, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 481-481
Open Access | Times Cited: 20
Nebulized Glutathione as a Key Antioxidant for the Treatment of Oxidative Stress in Neurodegenerative Conditions
João Vitor Lana, Alexandre Rios, Renata Takeyama, et al.
Nutrients (2024) Vol. 16, Iss. 15, pp. 2476-2476
Open Access | Times Cited: 18
Hydrogels and Nanogels: Pioneering the Future of Advanced Drug Delivery Systems
Ernesto J. Delgado-Pujol, Guillermo Martínez, David Casado-Jurado, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 215-215
Open Access | Times Cited: 5
Thermosensitive in situ hydrogels of rivastigmine-loaded lipid-based nanosystems for nose-to-brain delivery: characterisation, biocompatibility, and drug deposition studies
Sara Cunha, Magda Swedrowska, Y. Bellahnid, et al.
International Journal of Pharmaceutics (2022) Vol. 620, pp. 121720-121720
Closed Access | Times Cited: 43
Self-healing hydrogel as an injectable implant: translation in brain diseases
Junpeng Xu, Shan‐hui Hsu
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 29
Intranasal Drug Administration in Alzheimer-Type Dementia: Towards Clinical Applications
Raquel Taléns‐Visconti, Jesús Vicente de Julián-Ortiz, Ofelia Vila-Busó, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1399-1399
Open Access | Times Cited: 27
Mesoporous silica nanoparticles: Their potential as drug delivery carriers and nanoscavengers in Alzheimer's and Parkinson's diseases
Mohamed S. Attia, Ahmed Saeed Yahya, Nada Abdel Monaem, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 3, pp. 417-432
Open Access | Times Cited: 25
Solubilization techniques used for poorly water-soluble drugs
Bing Xie, Yaping Liu, Xiaotong Li, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 11, pp. 4683-4716
Open Access | Times Cited: 14
Rivastigmine nasal spray for the treatment of Alzheimer’s Disease: Olfactory deposition and brain delivery
Haihua Guo, Guanlin Wang, Zizhao Zhai, et al.
International Journal of Pharmaceutics (2024) Vol. 652, pp. 123809-123809
Closed Access | Times Cited: 12
A comprehensive insight of innovations and recent advancements in nanocarriers for nose-to-brain drug targeting
Naeem Mubarak, Muhammad Ahsan Waqar, Asad Majeed Khan, et al.
Designed Monomers & Polymers (2025) Vol. 28, Iss. 1, pp. 7-29
Open Access | Times Cited: 1
New Drug Delivery Systems Developed for Brain Targeting
Shruti Rawal, Bhoomika M. Patel, Mayur M. Patel
Drugs (2022) Vol. 82, Iss. 7, pp. 749-792
Closed Access | Times Cited: 32
Navigating the Maze of Alzheimer’s disease by exploring BACE1: Discovery, current scenario, and future prospects
Faiza Iram, Mohammad Shahid, Jaoud Ansari, et al.
Ageing Research Reviews (2024) Vol. 98, pp. 102342-102342
Closed Access | Times Cited: 7
Quercetin-Loaded Nanostructured Lipid Carrier In Situ Gel for Brain Targeting Through Intranasal Route: Formulation, In Vivo Pharmacokinetic and Pharmacodynamic Studies
Devika Sonawane, Varsha Pokharkar
AAPS PharmSciTech (2024) Vol. 25, Iss. 2
Closed Access | Times Cited: 6
Drug Delivery Systems as a Strategy to Improve the Efficacy of FDA-Approved Alzheimer’s Drugs
Débora Nunes, Joana A. Loureiro, Maria do Carmo Pereira
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2296-2296
Open Access | Times Cited: 27
Drug delivery to the brain: In situ gelling formulation enhances carbamazepine diffusion through nasal mucosa models with mucin
Elisa Corazza, Massimiliano Pio di Cagno, Annette Bauer‐Brandl, et al.
European Journal of Pharmaceutical Sciences (2022) Vol. 179, pp. 106294-106294
Open Access | Times Cited: 26
Intranasal Administration of a TRAIL Neutralizing Monoclonal Antibody Adsorbed in PLGA Nanoparticles and NLC Nanosystems: An In Vivo Study on a Mouse Model of Alzheimer’s Disease
Teresa Musumeci, Giulia Di Benedetto, Claudia Carbone, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 985-985
Open Access | Times Cited: 24
Exploring the potential to enhance drug distribution in the brain subregion via intranasal delivery of nanoemulsion in combination with borneol as a guider
Shen Xin, Zhixiang Cui, Yidan Wei, et al.
Asian Journal of Pharmaceutical Sciences (2023) Vol. 18, Iss. 6, pp. 100778-100778
Open Access | Times Cited: 15
In situ hydrogel containing diazepam-loaded nanostructured lipid carriers (DZP-NLC) for nose-to-brain delivery: development, characterization and deposition studies in a 3D-printed human nasal cavity model
Cláudia Pina Costa, Laura Nižić Nodilo, Renata Silva, et al.
International Journal of Pharmaceutics (2023) Vol. 644, pp. 123345-123345
Open Access | Times Cited: 15
Design of experiment (DoE) as a quality by design (QbD) tool to optimise formulations of lipid nanoparticles for nose-to-brain drug delivery
Aline de Alcântara Correia, João Nuno Moreira, José Manuel Sousa Lobo, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 12, pp. 1731-1748
Closed Access | Times Cited: 14
Intranasal in situ gelling liquid crystal for delivery of resveratrol ameliorates memory and neuroinflammation in Alzheimer's disease
Bruno Fonseca‐Santos, Camila André Cazarin, Patrícia Bento da Silva, et al.
Nanomedicine Nanotechnology Biology and Medicine (2023) Vol. 51, pp. 102689-102689
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top